Loading organizations...
Loading organizations...
Developer of gene therapies for severe central nervous system diseases.
Taysha Gene Therapies has raised $275.0M across 4 funding rounds.
Taysha Gene Therapies has raised $275.0M in total across 4 funding rounds.
Taysha Gene Therapies has raised $275.0M in total across 4 funding rounds.
Taysha Gene Therapies's investors include Naoki Okamura, Silicon Valley Bank, Fidelity Management & Research Company, ArrowMark Partners, BlackRock, Casdin Capital, Franklin Templeton, Google Ventures, Invus, Octagon Capital, PBM Capital, Perceptive Advisors.
Taysha Gene Therapies has raised $275.0M across 4 funding rounds. Most recently, it raised $50.0M Other Equity in October 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 24, 2022 | $50.0M Other Equity | Naoki Okamura | |
| Aug 16, 2021 | $100.0M Debt | Silicon Valley Bank | |
| Aug 5, 2020 | $95.0M Series B | Fidelity Management & Research Company | ArrowMark Partners, BlackRock, Casdin Capital, Franklin Templeton, Google Ventures, Invus, Octagon Capital, PBM Capital, Perceptive Advisors, Sands Capital, Venrock |
| Apr 29, 2020 | $30.0M Seed | Sean Nolan, Paul Manning |